APA (7th ed.) Citation

Wu, C., Mahdi, A. K., Huang, C., Chen, C., Pan, Y., Chang, J. W., . . . Lunec, J. (2026). Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13 , 3876. Cancers, 18(3), 530. https://doi.org/10.3390/cancers18030530

Chicago Style (17th ed.) Citation

Wu, Chiao-En, Ahmed Khairallah Mahdi, Chen-Yang Huang, Chiao-Ping Chen, Yi-Ru Pan, John Wen-Cheng Chang, Jen-Shi Chen, Chun-Nan Yeh, and John Lunec. "Correction: Wu Et Al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced P53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13 , 3876." Cancers 18, no. 3 (2026): 530. https://doi.org/10.3390/cancers18030530.

MLA (9th ed.) Citation

Wu, Chiao-En, et al. "Correction: Wu Et Al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced P53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13 , 3876." Cancers, vol. 18, no. 3, 2026, p. 530, https://doi.org/10.3390/cancers18030530.